A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients
Clinical trial NCT00996476 · COMPLETED
Trial details
- NCT number
- NCT00996476
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-01-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.